Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S-Reference-Cited by-同舟云学术

Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S

Published:2023-08 Issue:37 Volume:41 Page:5351-5359
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Struyf Frank^ORCID,Hardt Karin,Van Rampelbergh Rian,Shukarev Georgi,Inamdar Ajinkya,Ruiz-Guiñazú Javier^ORCID,van Paassen Vitalija,Anaya-Velarde Luis,Diba Camellia,Ceuppens Marc,Cardenas Vicky,Soff Gerald A.,Pragalos Antoinette,Sadoff Jerald^ORCID,Douoguih Macaya

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations;Lavin;Br J Haematol,2021

2. Thrombosis with thrombocytopenia syndrome after administration of AZD1222 or Ad26.COV2.S vaccine for COVID-19: a systematic review;Waqar;Clin Appl Thromb Hemost,2021

3. Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: a self-controlled case series study in England;Higgins;Res Pract Thromb Haemost,2022

4. Heparin-induced thrombocytopenia in severe COVID-19;Daviet;Circulation,2020

5. Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases;Taquet;EClinicalMedicine,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia;Vaccines;2024-05-20

2. AD26.COV2-S;Reactions Weekly;2023-09-09